11.6 - Antithrombotic therapy in PAD

Rivaroxaban in peripheral artery disease after revascularisation

View next trial
One-year outcomes after PCI strategies in cardiogenic shock: CULPRIT SHOCK: 1 year

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Latest news